AnaptysBio, Inc.AnaptysBio, Inc.AnaptysBio, Inc.

AnaptysBio, Inc.

No trades
See on Supercharts

Price target

55.640.000.00%
The 11 analysts offering 1 year price forecasts for ANAB have a max estimate of — and a min estimate of —.

Analyst rating

Based on 12 analysts giving stock ratings to ANAB in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ANAB EPS for the last quarter is −1.71 USD despite the estimation of −1.04 USD. In the next quarter EPS is expected to reach −1.65 USD. Track more of AnaptysBio, Inc. financials and stay on top of what is up with the company.
In the next quarter AnaptysBio, Inc. revenue is expected to reach ‪8.21 M‬ USD. Check out AnaptysBio, Inc. revenue and earnings and make informed decisions.
According to analysts, ANAB price target is 55.64 USD with a max estimate of 90.00 USD and a min estimate of 30.00 USD. Check if this forecast comes true in a year, meanwhile watch AnaptysBio, Inc. stock price chart and keep track of the current situation with ANAB news and stock market news.
We've gathered opinions of 12 analysts rating ANAB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.